Observational studyFrontiers in immunology2023

Natalizumab-immunogenicity evaluation in patients with infusion related events or disease exacerbations.

Nicolás Lundahl Ciano-Petersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.